JEWEL :: Jumping into rEal World Evidence Learning – A Program in Advanced Breast Cancer

bookLearning Objectives

  •  Describe and critically appraise real world evidence (RWE) in the Canadian context based on the methodology used to collect and analyze it.
  • Apply RWE to Canadian oncology clinical practice as a complement to evidence from RCTs – particularly existing real-world data for CDK4/6 inhibitors in metastatic breast cancer.



Thursday, September 16, 2021


7:00 pm - 8:00 pm


Registration is complimentary and restricted to healthcare professionals. Please click the button below to complete the transaction:

personAbout the Faculty

Elena Tsvetkova

Dr. Winson Cheung


Winson Y. Cheung, MD, MPH, FRCPC is a medical oncologist and a nationally and internationally recognized health services researcher. He is currently a Professor of Medicine in the Department of Oncology at the University of Calgary where he is the Provincial Director of Health Services Research for Cancer Control Alberta. Dr. Cheung’s primary research interest is health services and outcomes research. His projects focus on understanding the interplay of various patient, physician, and system level factors that drive practice patterns in the real world setting and learning how processes can be modified to better inform care. The overarching goal of his work is to ensure that cancer care is appropriately accessed and delivered to all patients.

Reshma Mahtani

Dr. Stephen Chia


Stephen K. Chia, M.D., F.R.C.P. (Canada) is an Associate Professor of Medicine, Department of Medicine at the University of British Columbia, Vancouver, Canada. He also is a staff oncologist with the British Columbia Cancer Agency (BCCA), Vancouver, Canada. In addition, Dr. Chia serves as Chair for the British Columbia Breast Tumour Group and is physician coordinator for both the breast cancer and head and neck cancer clinical trials at the BCCA – Vancouver Cancer Centre. Dr. Chia has been widely published (over 70 peer reviewed publications) in international peer-reviewed journals including New England Journal of Medicine, Journal of Clinical Oncology, Lancet, Journal of the National Cancer Institute, Cell, Annals of Oncology and Clinical Cancer Research. An active researcher, he is currently carrying out clinical and translational studies in breast cancer with peer reviewed grant funded research from the National Cancer Institute of Canada, National Institute of Health (USA), Canadian Breast Cancer Research Alliance and Canadian Breast Cancer Foundation – British Columbia/Yukon Chapter.


This program has been made possible through unrestricted support from Pfizer.